DIMETHYLFUMARAT Mepha Teva caps 240 mg 168 pce

7680695040036 CH-69504 L04AX07 01.99.0.

Active substances:

DIMETHYLFUMARAT Mepha Teva caps 240 mg 168 pce
DIMETHYLFUMARAT Mepha Teva caps 240 mg 168 pce
DIMETHYLFUMARAT Mepha Teva caps 240 mg 168 pce
1 / 3
google

Details

Product number
6950402
CPT
-
Packaging group
168
Unit
Kapsel(n)
Composition
dimethylis fumaras 240 mg, cellulosum microcristallinum, povidonum K 30, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, triacetinum, talcum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, E 171, triethylis citras, Kapselhülle: gelatina, E 171, E 172 (flavum), E 133, Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, E 172 (nigrum), pro capsula.

Articles (1)

Dimethylfumarat-Mepha Teva 240 mg, magensaftresistente Hartkapseln
Magensaftresistente Hartkapseln
168
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/07/2025
Patient information leaflet
Français
09/07/2025
Patient information leaflet
Italien
09/07/2025
Professional SmPC
Allemand
09/07/2025
Professional SmPC
Français
09/07/2025
Professional SmPC
Italien
09/07/2025

Detailed composition

Substance Quantity Type Category
dimethylis fumaras
240.0 MG Substance Wirkstoff (Principe actif)
cellulosum microcristallinum
- Substance HNIDK
povidonum K 30
- Substance HNIDK
crospovidonum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK
hypromellosum
- Substance HNIDK
triacetinum
- Substance HNIDK
talcum
- Substance HNIDK
acidi methacrylici et ethylis acrylatis polymerisatum 1:1
- Substance HNIDK
E 171
- Substance FNIDK
triethylis citras
- Substance HNIDK
gelatina
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (flavum)
- Substance FTODK
E 133
- Substance FIMDK
lacca
- Substance HNIDK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
ammoniae solutio concentrata
- Substance HNIDK
kalii hydroxidum
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK

Reimbursement information

Public price
CHF 1176.35
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/09/2024

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
69504
Drug name
Dimethylfumarat-Mepha Teva, magensaftresistente Hartkapseln
Galenic form
KAHAM
ATC Code
L04AX07
Authorization status
Z
Dispensation category
B
First authorization
08/08/2024
Authorization expiration date
07/08/2029
IT number
01.99.0.
Domain
Human medicine
Field of application
Multiple Sklerose

Packaging details

Description (FR)
DIMETHYLFUMARAT Mepha Teva caps 240 mg 168 pce
Description (DE)
DIMETHYLFUMARAT Mepha Teva Kaps 240 mg 168 Stk
Market launch
08/08/2024
Narcotic (BTM)
No

Original drug

Tecfidera, magensaftresistente Hartkapseln
CHF 287.50
View original

Other packaging sizes

DIMETHYLFUMARAT Mepha Teva caps 120 mg 14 pce
14 KAP
View
DIMETHYLFUMARAT Mepha Teva caps 240 mg 56 pce
56 KAP
View
Buy us a coffee Explore the data